Public health value of universal HPV vaccination

Slides:

Advertisements

Similar presentations

Analysis of health stories in daily newspapers in the UK A. Robinson, A. Coutinho, A. Bryden, M. McKee Public Health Volume 127, Issue 1, Pages (January.

Advertisements

Mobile health IT: The effect of user interface and form factor on doctor–patient communication Ole Andreas Alsos, Anita Das, Dag Svanæs International Journal.

Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,

Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /

Critical Reviews in Oncology / Hematology

Eribulin—A review of preclinical and clinical studies

Gastric cancer Critical Reviews in Oncology / Hematology

Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi

Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer

Exercise issues in older cancer survivors

Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review Cloé Brami, Ting Bao, Gary Deng Critical.

Thyroid cancer burden in Central and South America

Thyroid cancer burden in Central and South America

Novel targets in gastric and esophageal cancer

Critical Reviews in Oncology / Hematology

Nicoletta Colombo, Martin Gore

A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications Mitchell E. Reff, Cheryl Heard Critical Reviews.

Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions? Séverine Guiu, Anita Wolfer, William Jacot, Pierre.

Philipp Dahm, Ari D. Silverstein, Alon Z

Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force Silvio Monfardini,

The HPV Vaccine: Rates, Attitudes and Acceptibility

Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis

The case for wider use of recombinant factor VIII concentrates

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer Sandro Pignata, Enrico.

Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature Omar Abdel-Rahman,

Marion Piñeros, Mónica S. Sierra, M. Isabel Izarzugaza, David Forman

Volume 44, Pages S43-S52 (September 2016)

Stomach cancer burden in Central and South America

Prostate cancer burden in Central and South America

Cancer patterns and trends in Central and South America

Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead J. Carlijn Van Gaal, Eveline S.J.M. De Bont, Suzanne.

Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey Lazzaro Repetto Critical.

The see-saw of Keap1-Nrf2 pathway in cancer

Amy M. Lin, Charles J. Ryan, Eric J. Small

Genistein: Its role in metabolic diseases and cancer

Figure 1 Estimated annual percentages of new

Abhimanyu Ghose, Ria Kundu, Tahir Latif

Critical Reviews in Oncology / Hematology

Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging Vincenzo Solfrizzi, Emanuele Scafato, Vincenza Frisardi,

P. Therasse, S. Carbonnelle, J. Bogaerts

Olfa Baroudi, Amel Benammar-elgaaied

Long non-coding RNA CASC2 in human cancer

Managing Cancer Pain: Basic Principles and Invasive Treatments

Gwo Yaw Ho, Natasha Woodward, Jermaine I.G. Coward

Critical Reviews in Oncology / Hematology

Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence Ashish Singhal, Muralidharan Jayaraman, Danny.

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello Critical.

Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders Mai F. Tolba, Hany A.

Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up Marco Lucchi, MD, Franca Melfi, MD, Paolo.

William L. Lanier, MD Mayo Clinic Proceedings

Human papilloma viruses and cancer in the post-vaccine era

Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus T. Bärnighausen, D.E. Bloom, E.T. Cafiero,

Are patients willing to travel for better ovarian cancer care?

The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan Kaoru Yamabe, MSc, Puneet K. Singhal,

Volume 61, Issue 5, Pages (May 2012)

Electronic Updates for JTO Readers

Glenn E Talboy, Kamani Lankachandra, Diane M Harper

Volume 152, Issue 1, (January 2013)

European Urology is “Your” Journal

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

CPR 1.2.: Evaluation of Anemia in CKD

A Nearly Missed Catastrophic Aortic Injury After Reduction of a Thoracic Spine Fracture Managed by Prompt Endovascular Treatment Antonio Salsano, MD,

Urine-Based HPV Testing as a Method to Screen for Cervical Cancer

Inside This Issue Experimental Hematology

Table of contents The Journal for Nurse Practitioners

Comment on the article “Age and liver transplantation”

European Lung Cancer Conference (ELCC) 2016 Organisation

Managing Cancer Pain: Basic Principles and Invasive Treatments

Volume 148, Issue 1, (January 2012)

ED04.01 Surgery in Bronchopulmonary Typical and Atypical Carcinoids

Presentation transcript:

Public health value of universal HPV vaccination Riccardo A. Audisio, Giancarlo Icardi, Andrea M. Isidori, Carlo A. Liverani, Alberto Lombardi, Luciano Mariani, Francesco Saverio Mennini, David A. Mitchell, Andrea Peracino, Sergio Pecorelli, Giovanni Rezza, Carlo Signorelli, Giovanni Vitali Rosati, Gian Vincenzo Zuccotti Critical Reviews in Oncology / Hematology Volume 97, Pages 157-167 (January 2016) DOI: 10.1016/j.critrevonc.2015.07.015 Copyright © 2015 Terms and Conditions

Fig. 1 Estimate of the reduction of the remaining HPV-16,-18-genital and anal cancers burden in females in Europe through female-only HPV vaccination and universal HPV vaccination (age 12 years, 70% VCR). Critical Reviews in Oncology / Hematology 2016 97, 157-167DOI: (10.1016/j.critrevonc.2015.07.015) Copyright © 2015 Terms and Conditions

Fig. 2 Reduction of the remaining HPV-16,-18-anal cancer burden in females and males in Europe through female-only HPV vaccination and universal HPV vaccination (age 12 years, 70% VCR). Critical Reviews in Oncology / Hematology 2016 97, 157-167DOI: (10.1016/j.critrevonc.2015.07.015) Copyright © 2015 Terms and Conditions

Fig. 3 Reduction of the remaining HPV-6,-11-genital warts burden in females and males in Europe through female-only vaccination and universal vaccination (excluding HPV-related head/neck cancers) (age 12 years, 70% VCR). Critical Reviews in Oncology / Hematology 2016 97, 157-167DOI: (10.1016/j.critrevonc.2015.07.015) Copyright © 2015 Terms and Conditions